Sensato Investors LLC cut its stake in Bruker Co. (NASDAQ:BRKR) by 89.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,200 shares of the medical research company’s stock after selling 123,105 shares during the quarter. Sensato Investors LLC’s holdings in Bruker were worth $412,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. SG Americas Securities LLC purchased a new position in shares of Bruker in the 2nd quarter valued at $101,000. Meeder Asset Management Inc. increased its holdings in shares of Bruker by 501.4% in the 1st quarter. Meeder Asset Management Inc. now owns 4,697 shares of the medical research company’s stock valued at $140,000 after acquiring an additional 3,916 shares during the period. Sun Life Financial INC purchased a new position in shares of Bruker in the 2nd quarter valued at $163,000. TLP Group LLC purchased a new position in shares of Bruker in the 1st quarter valued at $190,000. Finally, Strs Ohio purchased a new position in shares of Bruker in the 2nd quarter valued at $327,000. Institutional investors and hedge funds own 65.61% of the company’s stock.

Shares of BRKR stock opened at $35.27 on Wednesday. Bruker Co. has a 1-year low of $28.13 and a 1-year high of $36.53. The company has a current ratio of 2.22, a quick ratio of 1.27 and a debt-to-equity ratio of 0.26. The firm has a market cap of $5.51 billion, a P/E ratio of 29.15, a price-to-earnings-growth ratio of 2.23 and a beta of 1.33.

Bruker (NASDAQ:BRKR) last announced its earnings results on Thursday, August 2nd. The medical research company reported $0.25 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.25. Bruker had a return on equity of 27.03% and a net margin of 4.99%. The firm had revenue of $443.70 million for the quarter, compared to the consensus estimate of $436.10 million. During the same period in the previous year, the business earned $0.23 EPS. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. equities research analysts forecast that Bruker Co. will post 1.38 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 21st. Investors of record on Tuesday, September 4th will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, August 31st. This represents a $0.16 annualized dividend and a yield of 0.45%. Bruker’s dividend payout ratio (DPR) is 13.22%.

A number of brokerages have recently issued reports on BRKR. BidaskClub upgraded Bruker from a “strong sell” rating to a “sell” rating in a report on Wednesday, July 25th. Zacks Investment Research downgraded Bruker from a “buy” rating to a “hold” rating in a report on Thursday, May 17th. ValuEngine downgraded Bruker from a “hold” rating to a “sell” rating in a report on Wednesday, July 11th. Finally, Morgan Stanley lifted their price target on Bruker from $29.00 to $31.00 and gave the company an “equal weight” rating in a report on Friday, August 3rd. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $33.20.

Bruker Profile

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.

Recommended Story: What is a closed-end mutual fund (CEF)?

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.